Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Search for extraterrestrial point sources of neutrinos with AMANDA-II.
Ahrens J, Bai X, Barwick SW, Becka T, Becker JK, Bernardini E, Bertrand D, Binon F, Biron A, Boersma DJ, Böser S, Botner O, Bouchta A, Bouhali O, Burgess T, Carius S, Castermans T, Chen A, Chirkin D, Collin B, Conrad J, Cooley J, Cowen DF, Davour A, De Clercq C, DeYoung T, Desiati P, Dewulf JP, Ekström P, Feser T, Gaisser TK, Ganugapati R, Gaug M, Geenen H, Gerhardt L, Goldschmidt A, Gross A, Hallgren A, Halzen F, Hanson K, Hardtke R, Harenberg T, Hauschildt T, Helbing K, Hellwig M, Herquet P, Hill GC, Hubert D, Hughey B, Hulth PO, Hultqvist K, Hundertmark S, Jacobsen J, Karle A, Kestel M, Köpke L, Kowalski M, Kuehn K, Lamoureux JI, Leich H, Leuthold M, Lindahl P, Liubarsky I, Madsen J, Mandli K, Marciniewski P, Matis HS, McParland CP, Messarius T, Minaeva Y, Miocinović P, Morse R, Münich K, Nahnhauer R, Neunhöffer T, Niessen P, Nygren DR, Ogelman H, Olbrechts P, Pérez de los Heros C, Pohl AC, Porrata R, Price PB, Przybylski GT, Rawlins K, Resconi E, Rhode W, Ribordy M, Richter S, Rodríguez Martino J, Sander HG, Schinarakis K, Schlenstedt S, Schmidt T, Schneider D, Schwarz R, Silvestri A, Solarz M, Spiczak GM, Spiering C, Stamatikos M, Steele D, Steffen P, Stokstad RG, Sula… See abstract for full author list ➔ Ahrens J, et al. Among authors: neunhoffer t. Phys Rev Lett. 2004 Feb 20;92(7):071102. doi: 10.1103/PhysRevLett.92.071102. Epub 2004 Feb 19. Phys Rev Lett. 2004. PMID: 14995836 Free article.
Limits on diffuse fluxes of high energy extraterrestrial neutrinos with the AMANDA-B10 detector.
Ahrens J, Bai X, Barwick SW, Bay RC, Becka T, Becker KH, Bernardini E, Bertrand D, Biron A, Boeser S, Botner O, Bouchta A, Bouhali O, Burgess T, Carius S, Castermans T, Chirkin D, Conrad J, Cooley J, Cowen DF, Davour A, De Clercq C, DeYoung T, Desiati P, Doksus P, Ekström P, Feser T, Gaisser TK, Ganugapati R, Gaug M, Geenen H, Gerhardt L, Goldschmidt A, Hallgren A, Halzen F, Hanson K, Hardtke R, Hauschildt T, Hellwig M, Herquet P, Hill GC, Hulth PO, Hughey B, Hultqvist K, Hundertmark S, Jacobsen J, Karle A, Kuehn K, Kim J, Köpke L, Kowalski M, Lamoureux JI, Leich H, Leuthold M, Lindahl P, Liubarsky I, Madsen J, Mandli K, Marciniewski P, Matis H, McParland CP, Messarius T, Miller TC, Minaeva Y, Miocinović P, Mock PC, Morse R, Neunhöffer T, Niessen P, Nygren DR, Ogelman H, Olbrechts P, Pérez de los Heros C, Pohl AC, Porrata R, Price PB, Przybylski GT, Rawlins K, Resconi E, Rhode W, Ribordy M, Richter S, Martino JR, Romenesko P, Ross D, Sander HG, Schlenstedt S, Schinarakis K, Schmidt T, Schneider D, Schwarz R, Silvestri A, Solarz M, Stamatikos M, Spiczak GM, Spiering C, Steele D, Steffen P, Stokstad RG, Sulanke KH, Taboada I, Tilav S, Wagner W, Walck C, Wang YR, Wiebusch CH, … See abstract for full author list ➔ Ahrens J, et al. Among authors: neunhoffer t. Phys Rev Lett. 2003 Jun 27;90(25 Pt 1):251101. doi: 10.1103/PhysRevLett.90.251101. Epub 2003 Jun 24. Phys Rev Lett. 2003. PMID: 12857122
Observation of high-energy neutrinos using Cerenkov detectors embedded deep in Antarctic ice.
Andrés E, Askebjer P, Bai X, Barouch G, Barwick SW, Bay RC, Becker KH, Bergström L, Bertrand D, Bierenbaum D, Biron A, Booth J, Botner O, Bouchta A, Boyce MM, Carius S, Chen A, Chirkin D, Conrad J, Cooley J, Costa CG, Cowen DF, Dailing J, Dalberg E, DeYoung T, Desiati P, Dewulf JP, Doksus P, Edsjö J, Ekström P, Erlandsson B, Feser T, Gaug M, Goldschmidt A, Goobar A, Gray L, Haase H, Hallgren A, Halzen F, Hanson K, Hardtke R, He YD, Hellwig M, Heukenkamp H, Hill GC, Hulth PO, Hundertmark S, Jacobsen J, Kandhadai V, Karle A, Kim J, Koci B, Köpke L, Kowalski M, Leich H, Leuthold M, Lindahl P, Liubarsky I, Loaiza P, Lowder DM, Ludvig J, Madsen J, Marciniewski P, Matis HS, Mihalyi A, Mikolajski T, Miller TC, Minaeva Y, Miocinović P, Mock PC, Morse R, Neunhöffer T, Newcomer FM, Niessen P, Nygren DR, Ogelman H, Pérez de los Heros C, Porrata R, Price PB, Rawlins K, Reed C, Rhode W, Richards A, Richter S, Martino JR, Romenesko P, Ross D, Rubinstein H, Sander HG, Scheider T, Schmidt T, Schneider D, Schneider E, Schwarz R, Silvestri A, Solarz M, Spiczak GM, Spiering C, Starinsky N, Steele D, Steffen P, Stokstad RG, Streicher O, Sun Q, Taboada I, Thollander L, Thon T, Tilav S, Usechak … See abstract for full author list ➔ Andrés E, et al. Among authors: neunhoffer t. Nature. 2001 Mar 22;410(6827):441-3. doi: 10.1038/35068509. Nature. 2001. PMID: 11260705
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, González-Martin A, Gargiulo P, Lück HJ, Genestie C; PAOLA-1 investigators; Ray-Coquard I, Pujade-Lauraine E, Vaur D. Leman R, et al. Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry.
Riecke K, Müller V, Neunhöffer T, Park-Simon TW, Weide R, Polasik A, Schmidt M, Puppe J, Mundhenke C, Lübbe K, Hesse T, Thill M, Wuerstlein R, Denkert C, Decker T, Fehm T, Nekljudova V, Rey J, Loibl S, Laakmann E, Witzel I. Riecke K, et al. Among authors: neunhoffer t. ESMO Open. 2023 Jun;8(3):101213. doi: 10.1016/j.esmoop.2023.101213. Epub 2023 Apr 17. ESMO Open. 2023. PMID: 37075697 Free PMC article.
Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry.
Laakmann E, Witzel I, Neunhöffer T, Park-Simon TW, Weide R, Riecke K, Polasik A, Schmidt M, Puppe J, Mundhenke C, Lübbe K, Hesse T, Thill M, Zahm DM, Denkert C, Fehm T, Nekljudova V, Rey J, Loibl S, Müller V. Laakmann E, et al. Among authors: neunhoffer t. ESMO Open. 2022 Jun;7(3):100495. doi: 10.1016/j.esmoop.2022.100495. Epub 2022 May 30. ESMO Open. 2022. PMID: 35653983 Free PMC article.
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
Coombes RC, Tovey H, Kilburn L, Mansi J, Palmieri C, Bartlett J, Hicks J, Makris A, Evans A, Loibl S, Denkert C, Murray E, Grieve R, Coleman R, Borley A, Schmidt M, Rautenberg B, Kunze CA, Rhein U, Mehta K, Mousa K, Dibble T, Lu XL, von Minckwitz G, Bliss JM; Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators. Coombes RC, et al. JAMA Oncol. 2021 Sep 1;7(9):1291-1301. doi: 10.1001/jamaoncol.2021.2193. JAMA Oncol. 2021. PMID: 34264305 Free PMC article. Clinical Trial.
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases.
Laakmann E, Witzel I, Neunhöffer T, Weide R, Schmidt M, Park-Simon TW, Möbus V, Mundhenke C, Polasik A, Lübbe K, Hesse T, Riecke K, Thill M, Fasching PA, Denkert C, Fehm T, Nekljudova V, Rey J, Loibl S, Müller V. Laakmann E, et al. Among authors: neunhoffer t. Cancers (Basel). 2020 Sep 28;12(10):2787. doi: 10.3390/cancers12102787. Cancers (Basel). 2020. PMID: 32998430 Free PMC article.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Free article. Clinical Trial.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
17 results